Abstract
Patients with small-cell lung cancer who survive more than 2 years have a significantly increased risk (relative risk of 3.6) of developing a second primary tumour. The cessation of cigarette smoking after successful therapy is associated with a significantly decreased risk of a second primary tumour.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawahara, M., Ushijima, S., Kamimori, T. et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 78, 409–412 (1998). https://doi.org/10.1038/bjc.1998.507
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.507
This article is cited by
-
Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis
Journal of Cancer Research and Clinical Oncology (2023)
-
Prevalence and correlates of dual tobacco use in cancer survivors
Cancer Causes & Control (2019)
-
Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers
Journal of Community Health (2019)
-
Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study
British Journal of Cancer (2017)
-
Small-cell lung cancer: what we know, what we need to know and the path forward
Nature Reviews Cancer (2017)